Adhesion Barrier Market to Reach USD 2256.33 Million by 2028

Vantage Market Research

Nov 11, 2021

According to a new report by Vantage Market Research, the adhesion barrier market is expected to reach USD 2256.33 Million by 2028, growing at a CAGR of 7.02% from 2021 to 2028. Advancements in the infrastructure of healthcare and the rising accessibility of trauma care centers are anticipated to fuel the growth. Furthermore, rising sports-related injuries incidences are also helping to the market growth.

Key Findings:    

  • The Formulation segment is projected to grow at a CAGR of over 10.45% over the forecast period owing to changing busy lifestyles and ease to use.
  • The application segment is anticipated to be the dominating segment for the adhesion barrier market owing to the presence of a large base of the population suffering from Cardiovascular disorders, Neurological disorders, Urological disorders, Others.
  • North America is expected to expand at a CAGR of over 10.85% from 2021 to 2028. This surge is attributed to the presence of major players in the region.
  • Asia Pacific region is anticipated to grow at the fastest CAGR owing to the presence of a larger base population in countries such as China India among others.

Some of the key players in the adhesion barrier market include Atrium Medical Corporation, Anika Therapeutics Inc., MAST Biosurgery AG, Sanofi Group, Baxter International Inc., Integra Lifesciences Corporation, FzioMed Inc., C. R. Bard Inc., Johnson & Johnson, Medtronic Plc., Becton, Dickinson and Company, MAST Biosurgery, Innocoll Holdings, Betatech Medical, CorMatrix Cardiovascular, Inc., Terumo Corporation, BiosCompass, WL Gore & Associates, Allosource, among others.

The swift improvements in healthcare infrastructure and the availability of trauma care centers are expected to drive the growth. Also, along with changing awareness and lifestyle towards sports, incidences of sports-related injuries are also increasing which is further likely to [ropell the market growth. According to Stanford Children’s Health, around 30 million children participate in some form of sports, in which more than 10% have injuries each year. Moreover, according to CDC (Centers for Disease Control and Prevention) in 2015, around 51 Million orthopedic procedures were performed in the U.S. in the year. Thus, the increasing number of orthopedic procedures is anticipated to boost the adhesion barrier market growth in the near future over the forecast period.

North America is anticipated to hold the largest share of the adhesion barrier market owing to the presence of major players such as Baxter International, Integra LifeSciences, Johnson and Johnson, Anika Therapeutics, and FzioMed. The U.S. is expected to be dominating in the North American region.